The Mutation Profile and Prognosis in AML With IDH1/2 Mutation
NCT07004816
·
clinicaltrials.gov ↗
TERMINATED
Status
1015
Enrollment
OTHER
Sponsor class
Stopped
Adapted the plan
Conditions
AML
Interventions
OTHER:
Uncover mutation profiles
Sponsor
Institute of Hematology & Blood Diseases Hospital, China